Global Minimal Residual Disease (MRD) Testing Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Minimal Residual Disease (MRD) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Minimal Residual Disease (MRD) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Minimal Residual Disease (MRD) Testing market in any manner.
Global Minimal Residual Disease (MRD) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sysmex Corporation
Natera
Asuragen
Quest Diagnostics
Mission Bio
LabCorp
Guardant Health
NeoGenomics Laboratories
ARUP Laboratories
NeoGenomics , Inc
Opko Health
Bio-Rad Laboratories
Market Segmentation (by Type)
Flow Cytometry
Polymerase Chain Reaction
Next-generation Sequencing
Liquid Biopsies
Market Segmentation (by Application)
Specialty Clinics
Hospitals
Research Institutions
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Minimal Residual Disease (MRD) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Minimal Residual Disease (MRD) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Minimal Residual Disease (MRD) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Minimal Residual Disease (MRD) Testing market in any manner.
Global Minimal Residual Disease (MRD) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sysmex Corporation
Natera
Asuragen
Quest Diagnostics
Mission Bio
LabCorp
Guardant Health
NeoGenomics Laboratories
ARUP Laboratories
NeoGenomics , Inc
Opko Health
Bio-Rad Laboratories
Market Segmentation (by Type)
Flow Cytometry
Polymerase Chain Reaction
Next-generation Sequencing
Liquid Biopsies
Market Segmentation (by Application)
Specialty Clinics
Hospitals
Research Institutions
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Minimal Residual Disease (MRD) Testing Market
- Overview of the regional outlook of the Minimal Residual Disease (MRD) Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Minimal Residual Disease (MRD) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Minimal Residual Disease (MRD) Testing
1.2 Key Market Segments
1.2.1 Minimal Residual Disease (MRD) Testing Segment by Type
1.2.2 Minimal Residual Disease (MRD) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Minimal Residual Disease (MRD) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Minimal Residual Disease (MRD) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Minimal Residual Disease (MRD) Testing Sales by Manufacturers (2019-2024)
3.2 Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Minimal Residual Disease (MRD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Minimal Residual Disease (MRD) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Minimal Residual Disease (MRD) Testing Sales Sites, Area Served, Product Type
3.6 Minimal Residual Disease (MRD) Testing Market Competitive Situation and Trends
3.6.1 Minimal Residual Disease (MRD) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Minimal Residual Disease (MRD) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MINIMAL RESIDUAL DISEASE (MRD) TESTING INDUSTRY CHAIN ANALYSIS
4.1 Minimal Residual Disease (MRD) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Minimal Residual Disease (MRD) Testing Sales Market Share by Type (2019-2024)
6.3 Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2019-2024)
6.4 Global Minimal Residual Disease (MRD) Testing Price by Type (2019-2024)
7 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Minimal Residual Disease (MRD) Testing Market Sales by Application (2019-2024)
7.3 Global Minimal Residual Disease (MRD) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Minimal Residual Disease (MRD) Testing Sales Growth Rate by Application (2019-2024)
8 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET SEGMENTATION BY REGION
8.1 Global Minimal Residual Disease (MRD) Testing Sales by Region
8.1.1 Global Minimal Residual Disease (MRD) Testing Sales by Region
8.1.2 Global Minimal Residual Disease (MRD) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Minimal Residual Disease (MRD) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Minimal Residual Disease (MRD) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Minimal Residual Disease (MRD) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Minimal Residual Disease (MRD) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Minimal Residual Disease (MRD) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sysmex Corporation
9.1.1 Sysmex Corporation Minimal Residual Disease (MRD) Testing Basic Information
9.1.2 Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Overview
9.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Market Performance
9.1.4 Sysmex Corporation Business Overview
9.1.5 Sysmex Corporation Minimal Residual Disease (MRD) Testing SWOT Analysis
9.1.6 Sysmex Corporation Recent Developments
9.2 Natera
9.2.1 Natera Minimal Residual Disease (MRD) Testing Basic Information
9.2.2 Natera Minimal Residual Disease (MRD) Testing Product Overview
9.2.3 Natera Minimal Residual Disease (MRD) Testing Product Market Performance
9.2.4 Natera Business Overview
9.2.5 Natera Minimal Residual Disease (MRD) Testing SWOT Analysis
9.2.6 Natera Recent Developments
9.3 Asuragen
9.3.1 Asuragen Minimal Residual Disease (MRD) Testing Basic Information
9.3.2 Asuragen Minimal Residual Disease (MRD) Testing Product Overview
9.3.3 Asuragen Minimal Residual Disease (MRD) Testing Product Market Performance
9.3.4 Asuragen Minimal Residual Disease (MRD) Testing SWOT Analysis
9.3.5 Asuragen Business Overview
9.3.6 Asuragen Recent Developments
9.4 Quest Diagnostics
9.4.1 Quest Diagnostics Minimal Residual Disease (MRD) Testing Basic Information
9.4.2 Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Overview
9.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Market Performance
9.4.4 Quest Diagnostics Business Overview
9.4.5 Quest Diagnostics Recent Developments
9.5 Mission Bio
9.5.1 Mission Bio Minimal Residual Disease (MRD) Testing Basic Information
9.5.2 Mission Bio Minimal Residual Disease (MRD) Testing Product Overview
9.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Product Market Performance
9.5.4 Mission Bio Business Overview
9.5.5 Mission Bio Recent Developments
9.6 LabCorp
9.6.1 LabCorp Minimal Residual Disease (MRD) Testing Basic Information
9.6.2 LabCorp Minimal Residual Disease (MRD) Testing Product Overview
9.6.3 LabCorp Minimal Residual Disease (MRD) Testing Product Market Performance
9.6.4 LabCorp Business Overview
9.6.5 LabCorp Recent Developments
9.7 Guardant Health
9.7.1 Guardant Health Minimal Residual Disease (MRD) Testing Basic Information
9.7.2 Guardant Health Minimal Residual Disease (MRD) Testing Product Overview
9.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Product Market Performance
9.7.4 Guardant Health Business Overview
9.7.5 Guardant Health Recent Developments
9.8 NeoGenomics Laboratories
9.8.1 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Basic Information
9.8.2 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Overview
9.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Market Performance
9.8.4 NeoGenomics Laboratories Business Overview
9.8.5 NeoGenomics Laboratories Recent Developments
9.9 ARUP Laboratories
9.9.1 ARUP Laboratories Minimal Residual Disease (MRD) Testing Basic Information
9.9.2 ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Overview
9.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Market Performance
9.9.4 ARUP Laboratories Business Overview
9.9.5 ARUP Laboratories Recent Developments
9.10 NeoGenomics , Inc
9.10.1 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Basic Information
9.10.2 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Overview
9.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Market Performance
9.10.4 NeoGenomics , Inc Business Overview
9.10.5 NeoGenomics , Inc Recent Developments
9.11 Opko Health
9.11.1 Opko Health Minimal Residual Disease (MRD) Testing Basic Information
9.11.2 Opko Health Minimal Residual Disease (MRD) Testing Product Overview
9.11.3 Opko Health Minimal Residual Disease (MRD) Testing Product Market Performance
9.11.4 Opko Health Business Overview
9.11.5 Opko Health Recent Developments
9.12 Bio-Rad Laboratories
9.12.1 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Basic Information
9.12.2 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Overview
9.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Market Performance
9.12.4 Bio-Rad Laboratories Business Overview
9.12.5 Bio-Rad Laboratories Recent Developments
10 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET FORECAST BY REGION
10.1 Global Minimal Residual Disease (MRD) Testing Market Size Forecast
10.2 Global Minimal Residual Disease (MRD) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Minimal Residual Disease (MRD) Testing Market Size Forecast by Country
10.2.3 Asia Pacific Minimal Residual Disease (MRD) Testing Market Size Forecast by Region
10.2.4 South America Minimal Residual Disease (MRD) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Minimal Residual Disease (MRD) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Minimal Residual Disease (MRD) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Minimal Residual Disease (MRD) Testing by Type (2025-2030)
11.1.2 Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Minimal Residual Disease (MRD) Testing by Type (2025-2030)
11.2 Global Minimal Residual Disease (MRD) Testing Market Forecast by Application (2025-2030)
11.2.1 Global Minimal Residual Disease (MRD) Testing Sales (K Units) Forecast by Application
11.2.2 Global Minimal Residual Disease (MRD) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Minimal Residual Disease (MRD) Testing
1.2 Key Market Segments
1.2.1 Minimal Residual Disease (MRD) Testing Segment by Type
1.2.2 Minimal Residual Disease (MRD) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Minimal Residual Disease (MRD) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Minimal Residual Disease (MRD) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Minimal Residual Disease (MRD) Testing Sales by Manufacturers (2019-2024)
3.2 Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Minimal Residual Disease (MRD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Minimal Residual Disease (MRD) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Minimal Residual Disease (MRD) Testing Sales Sites, Area Served, Product Type
3.6 Minimal Residual Disease (MRD) Testing Market Competitive Situation and Trends
3.6.1 Minimal Residual Disease (MRD) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Minimal Residual Disease (MRD) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MINIMAL RESIDUAL DISEASE (MRD) TESTING INDUSTRY CHAIN ANALYSIS
4.1 Minimal Residual Disease (MRD) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Minimal Residual Disease (MRD) Testing Sales Market Share by Type (2019-2024)
6.3 Global Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2019-2024)
6.4 Global Minimal Residual Disease (MRD) Testing Price by Type (2019-2024)
7 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Minimal Residual Disease (MRD) Testing Market Sales by Application (2019-2024)
7.3 Global Minimal Residual Disease (MRD) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Minimal Residual Disease (MRD) Testing Sales Growth Rate by Application (2019-2024)
8 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET SEGMENTATION BY REGION
8.1 Global Minimal Residual Disease (MRD) Testing Sales by Region
8.1.1 Global Minimal Residual Disease (MRD) Testing Sales by Region
8.1.2 Global Minimal Residual Disease (MRD) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Minimal Residual Disease (MRD) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Minimal Residual Disease (MRD) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Minimal Residual Disease (MRD) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Minimal Residual Disease (MRD) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Minimal Residual Disease (MRD) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sysmex Corporation
9.1.1 Sysmex Corporation Minimal Residual Disease (MRD) Testing Basic Information
9.1.2 Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Overview
9.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Market Performance
9.1.4 Sysmex Corporation Business Overview
9.1.5 Sysmex Corporation Minimal Residual Disease (MRD) Testing SWOT Analysis
9.1.6 Sysmex Corporation Recent Developments
9.2 Natera
9.2.1 Natera Minimal Residual Disease (MRD) Testing Basic Information
9.2.2 Natera Minimal Residual Disease (MRD) Testing Product Overview
9.2.3 Natera Minimal Residual Disease (MRD) Testing Product Market Performance
9.2.4 Natera Business Overview
9.2.5 Natera Minimal Residual Disease (MRD) Testing SWOT Analysis
9.2.6 Natera Recent Developments
9.3 Asuragen
9.3.1 Asuragen Minimal Residual Disease (MRD) Testing Basic Information
9.3.2 Asuragen Minimal Residual Disease (MRD) Testing Product Overview
9.3.3 Asuragen Minimal Residual Disease (MRD) Testing Product Market Performance
9.3.4 Asuragen Minimal Residual Disease (MRD) Testing SWOT Analysis
9.3.5 Asuragen Business Overview
9.3.6 Asuragen Recent Developments
9.4 Quest Diagnostics
9.4.1 Quest Diagnostics Minimal Residual Disease (MRD) Testing Basic Information
9.4.2 Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Overview
9.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Market Performance
9.4.4 Quest Diagnostics Business Overview
9.4.5 Quest Diagnostics Recent Developments
9.5 Mission Bio
9.5.1 Mission Bio Minimal Residual Disease (MRD) Testing Basic Information
9.5.2 Mission Bio Minimal Residual Disease (MRD) Testing Product Overview
9.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Product Market Performance
9.5.4 Mission Bio Business Overview
9.5.5 Mission Bio Recent Developments
9.6 LabCorp
9.6.1 LabCorp Minimal Residual Disease (MRD) Testing Basic Information
9.6.2 LabCorp Minimal Residual Disease (MRD) Testing Product Overview
9.6.3 LabCorp Minimal Residual Disease (MRD) Testing Product Market Performance
9.6.4 LabCorp Business Overview
9.6.5 LabCorp Recent Developments
9.7 Guardant Health
9.7.1 Guardant Health Minimal Residual Disease (MRD) Testing Basic Information
9.7.2 Guardant Health Minimal Residual Disease (MRD) Testing Product Overview
9.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Product Market Performance
9.7.4 Guardant Health Business Overview
9.7.5 Guardant Health Recent Developments
9.8 NeoGenomics Laboratories
9.8.1 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Basic Information
9.8.2 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Overview
9.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Market Performance
9.8.4 NeoGenomics Laboratories Business Overview
9.8.5 NeoGenomics Laboratories Recent Developments
9.9 ARUP Laboratories
9.9.1 ARUP Laboratories Minimal Residual Disease (MRD) Testing Basic Information
9.9.2 ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Overview
9.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Market Performance
9.9.4 ARUP Laboratories Business Overview
9.9.5 ARUP Laboratories Recent Developments
9.10 NeoGenomics , Inc
9.10.1 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Basic Information
9.10.2 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Overview
9.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Market Performance
9.10.4 NeoGenomics , Inc Business Overview
9.10.5 NeoGenomics , Inc Recent Developments
9.11 Opko Health
9.11.1 Opko Health Minimal Residual Disease (MRD) Testing Basic Information
9.11.2 Opko Health Minimal Residual Disease (MRD) Testing Product Overview
9.11.3 Opko Health Minimal Residual Disease (MRD) Testing Product Market Performance
9.11.4 Opko Health Business Overview
9.11.5 Opko Health Recent Developments
9.12 Bio-Rad Laboratories
9.12.1 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Basic Information
9.12.2 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Overview
9.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Market Performance
9.12.4 Bio-Rad Laboratories Business Overview
9.12.5 Bio-Rad Laboratories Recent Developments
10 MINIMAL RESIDUAL DISEASE (MRD) TESTING MARKET FORECAST BY REGION
10.1 Global Minimal Residual Disease (MRD) Testing Market Size Forecast
10.2 Global Minimal Residual Disease (MRD) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Minimal Residual Disease (MRD) Testing Market Size Forecast by Country
10.2.3 Asia Pacific Minimal Residual Disease (MRD) Testing Market Size Forecast by Region
10.2.4 South America Minimal Residual Disease (MRD) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Minimal Residual Disease (MRD) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Minimal Residual Disease (MRD) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Minimal Residual Disease (MRD) Testing by Type (2025-2030)
11.1.2 Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Minimal Residual Disease (MRD) Testing by Type (2025-2030)
11.2 Global Minimal Residual Disease (MRD) Testing Market Forecast by Application (2025-2030)
11.2.1 Global Minimal Residual Disease (MRD) Testing Sales (K Units) Forecast by Application
11.2.2 Global Minimal Residual Disease (MRD) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Minimal Residual Disease (MRD) Testing Market Size Comparison by Region (M USD)
Table 5. Global Minimal Residual Disease (MRD) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Minimal Residual Disease (MRD) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Minimal Residual Disease (MRD) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Testing as of 2022)
Table 10. Global Market Minimal Residual Disease (MRD) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Minimal Residual Disease (MRD) Testing Sales Sites and Area Served
Table 12. Manufacturers Minimal Residual Disease (MRD) Testing Product Type
Table 13. Global Minimal Residual Disease (MRD) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Minimal Residual Disease (MRD) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Minimal Residual Disease (MRD) Testing Market Challenges
Table 22. Global Minimal Residual Disease (MRD) Testing Sales by Type (K Units)
Table 23. Global Minimal Residual Disease (MRD) Testing Market Size by Type (M USD)
Table 24. Global Minimal Residual Disease (MRD) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Type (2019-2024)
Table 26. Global Minimal Residual Disease (MRD) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Minimal Residual Disease (MRD) Testing Market Size Share by Type (2019-2024)
Table 28. Global Minimal Residual Disease (MRD) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Minimal Residual Disease (MRD) Testing Sales (K Units) by Application
Table 30. Global Minimal Residual Disease (MRD) Testing Market Size by Application
Table 31. Global Minimal Residual Disease (MRD) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Application (2019-2024)
Table 33. Global Minimal Residual Disease (MRD) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Minimal Residual Disease (MRD) Testing Market Share by Application (2019-2024)
Table 35. Global Minimal Residual Disease (MRD) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Minimal Residual Disease (MRD) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Region (2019-2024)
Table 38. North America Minimal Residual Disease (MRD) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Minimal Residual Disease (MRD) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Minimal Residual Disease (MRD) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Minimal Residual Disease (MRD) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Minimal Residual Disease (MRD) Testing Sales by Region (2019-2024) & (K Units)
Table 43. Sysmex Corporation Minimal Residual Disease (MRD) Testing Basic Information
Table 44. Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Overview
Table 45. Sysmex Corporation Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Sysmex Corporation Business Overview
Table 47. Sysmex Corporation Minimal Residual Disease (MRD) Testing SWOT Analysis
Table 48. Sysmex Corporation Recent Developments
Table 49. Natera Minimal Residual Disease (MRD) Testing Basic Information
Table 50. Natera Minimal Residual Disease (MRD) Testing Product Overview
Table 51. Natera Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Natera Business Overview
Table 53. Natera Minimal Residual Disease (MRD) Testing SWOT Analysis
Table 54. Natera Recent Developments
Table 55. Asuragen Minimal Residual Disease (MRD) Testing Basic Information
Table 56. Asuragen Minimal Residual Disease (MRD) Testing Product Overview
Table 57. Asuragen Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Asuragen Minimal Residual Disease (MRD) Testing SWOT Analysis
Table 59. Asuragen Business Overview
Table 60. Asuragen Recent Developments
Table 61. Quest Diagnostics Minimal Residual Disease (MRD) Testing Basic Information
Table 62. Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Overview
Table 63. Quest Diagnostics Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Quest Diagnostics Business Overview
Table 65. Quest Diagnostics Recent Developments
Table 66. Mission Bio Minimal Residual Disease (MRD) Testing Basic Information
Table 67. Mission Bio Minimal Residual Disease (MRD) Testing Product Overview
Table 68. Mission Bio Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Mission Bio Business Overview
Table 70. Mission Bio Recent Developments
Table 71. LabCorp Minimal Residual Disease (MRD) Testing Basic Information
Table 72. LabCorp Minimal Residual Disease (MRD) Testing Product Overview
Table 73. LabCorp Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. LabCorp Business Overview
Table 75. LabCorp Recent Developments
Table 76. Guardant Health Minimal Residual Disease (MRD) Testing Basic Information
Table 77. Guardant Health Minimal Residual Disease (MRD) Testing Product Overview
Table 78. Guardant Health Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Guardant Health Business Overview
Table 80. Guardant Health Recent Developments
Table 81. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Basic Information
Table 82. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Overview
Table 83. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. NeoGenomics Laboratories Business Overview
Table 85. NeoGenomics Laboratories Recent Developments
Table 86. ARUP Laboratories Minimal Residual Disease (MRD) Testing Basic Information
Table 87. ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Overview
Table 88. ARUP Laboratories Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. ARUP Laboratories Business Overview
Table 90. ARUP Laboratories Recent Developments
Table 91. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Basic Information
Table 92. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Overview
Table 93. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. NeoGenomics , Inc Business Overview
Table 95. NeoGenomics , Inc Recent Developments
Table 96. Opko Health Minimal Residual Disease (MRD) Testing Basic Information
Table 97. Opko Health Minimal Residual Disease (MRD) Testing Product Overview
Table 98. Opko Health Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Opko Health Business Overview
Table 100. Opko Health Recent Developments
Table 101. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Basic Information
Table 102. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Overview
Table 103. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Bio-Rad Laboratories Business Overview
Table 105. Bio-Rad Laboratories Recent Developments
Table 106. Global Minimal Residual Disease (MRD) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Minimal Residual Disease (MRD) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Minimal Residual Disease (MRD) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Minimal Residual Disease (MRD) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Minimal Residual Disease (MRD) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Minimal Residual Disease (MRD) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Minimal Residual Disease (MRD) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Minimal Residual Disease (MRD) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Minimal Residual Disease (MRD) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Minimal Residual Disease (MRD) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Minimal Residual Disease (MRD) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Minimal Residual Disease (MRD) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Minimal Residual Disease (MRD) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Minimal Residual Disease (MRD) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Minimal Residual Disease (MRD) Testing Market Size Comparison by Region (M USD)
Table 5. Global Minimal Residual Disease (MRD) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Minimal Residual Disease (MRD) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Minimal Residual Disease (MRD) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Testing as of 2022)
Table 10. Global Market Minimal Residual Disease (MRD) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Minimal Residual Disease (MRD) Testing Sales Sites and Area Served
Table 12. Manufacturers Minimal Residual Disease (MRD) Testing Product Type
Table 13. Global Minimal Residual Disease (MRD) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Minimal Residual Disease (MRD) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Minimal Residual Disease (MRD) Testing Market Challenges
Table 22. Global Minimal Residual Disease (MRD) Testing Sales by Type (K Units)
Table 23. Global Minimal Residual Disease (MRD) Testing Market Size by Type (M USD)
Table 24. Global Minimal Residual Disease (MRD) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Type (2019-2024)
Table 26. Global Minimal Residual Disease (MRD) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Minimal Residual Disease (MRD) Testing Market Size Share by Type (2019-2024)
Table 28. Global Minimal Residual Disease (MRD) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Minimal Residual Disease (MRD) Testing Sales (K Units) by Application
Table 30. Global Minimal Residual Disease (MRD) Testing Market Size by Application
Table 31. Global Minimal Residual Disease (MRD) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Application (2019-2024)
Table 33. Global Minimal Residual Disease (MRD) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Minimal Residual Disease (MRD) Testing Market Share by Application (2019-2024)
Table 35. Global Minimal Residual Disease (MRD) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Minimal Residual Disease (MRD) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Region (2019-2024)
Table 38. North America Minimal Residual Disease (MRD) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Minimal Residual Disease (MRD) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Minimal Residual Disease (MRD) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Minimal Residual Disease (MRD) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Minimal Residual Disease (MRD) Testing Sales by Region (2019-2024) & (K Units)
Table 43. Sysmex Corporation Minimal Residual Disease (MRD) Testing Basic Information
Table 44. Sysmex Corporation Minimal Residual Disease (MRD) Testing Product Overview
Table 45. Sysmex Corporation Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Sysmex Corporation Business Overview
Table 47. Sysmex Corporation Minimal Residual Disease (MRD) Testing SWOT Analysis
Table 48. Sysmex Corporation Recent Developments
Table 49. Natera Minimal Residual Disease (MRD) Testing Basic Information
Table 50. Natera Minimal Residual Disease (MRD) Testing Product Overview
Table 51. Natera Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Natera Business Overview
Table 53. Natera Minimal Residual Disease (MRD) Testing SWOT Analysis
Table 54. Natera Recent Developments
Table 55. Asuragen Minimal Residual Disease (MRD) Testing Basic Information
Table 56. Asuragen Minimal Residual Disease (MRD) Testing Product Overview
Table 57. Asuragen Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Asuragen Minimal Residual Disease (MRD) Testing SWOT Analysis
Table 59. Asuragen Business Overview
Table 60. Asuragen Recent Developments
Table 61. Quest Diagnostics Minimal Residual Disease (MRD) Testing Basic Information
Table 62. Quest Diagnostics Minimal Residual Disease (MRD) Testing Product Overview
Table 63. Quest Diagnostics Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Quest Diagnostics Business Overview
Table 65. Quest Diagnostics Recent Developments
Table 66. Mission Bio Minimal Residual Disease (MRD) Testing Basic Information
Table 67. Mission Bio Minimal Residual Disease (MRD) Testing Product Overview
Table 68. Mission Bio Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Mission Bio Business Overview
Table 70. Mission Bio Recent Developments
Table 71. LabCorp Minimal Residual Disease (MRD) Testing Basic Information
Table 72. LabCorp Minimal Residual Disease (MRD) Testing Product Overview
Table 73. LabCorp Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. LabCorp Business Overview
Table 75. LabCorp Recent Developments
Table 76. Guardant Health Minimal Residual Disease (MRD) Testing Basic Information
Table 77. Guardant Health Minimal Residual Disease (MRD) Testing Product Overview
Table 78. Guardant Health Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Guardant Health Business Overview
Table 80. Guardant Health Recent Developments
Table 81. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Basic Information
Table 82. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product Overview
Table 83. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. NeoGenomics Laboratories Business Overview
Table 85. NeoGenomics Laboratories Recent Developments
Table 86. ARUP Laboratories Minimal Residual Disease (MRD) Testing Basic Information
Table 87. ARUP Laboratories Minimal Residual Disease (MRD) Testing Product Overview
Table 88. ARUP Laboratories Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. ARUP Laboratories Business Overview
Table 90. ARUP Laboratories Recent Developments
Table 91. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Basic Information
Table 92. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product Overview
Table 93. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. NeoGenomics , Inc Business Overview
Table 95. NeoGenomics , Inc Recent Developments
Table 96. Opko Health Minimal Residual Disease (MRD) Testing Basic Information
Table 97. Opko Health Minimal Residual Disease (MRD) Testing Product Overview
Table 98. Opko Health Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Opko Health Business Overview
Table 100. Opko Health Recent Developments
Table 101. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Basic Information
Table 102. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product Overview
Table 103. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Bio-Rad Laboratories Business Overview
Table 105. Bio-Rad Laboratories Recent Developments
Table 106. Global Minimal Residual Disease (MRD) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Minimal Residual Disease (MRD) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Minimal Residual Disease (MRD) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Minimal Residual Disease (MRD) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Minimal Residual Disease (MRD) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Minimal Residual Disease (MRD) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Minimal Residual Disease (MRD) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Minimal Residual Disease (MRD) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Minimal Residual Disease (MRD) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Minimal Residual Disease (MRD) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Minimal Residual Disease (MRD) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Minimal Residual Disease (MRD) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Minimal Residual Disease (MRD) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Minimal Residual Disease (MRD) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Minimal Residual Disease (MRD) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Minimal Residual Disease (MRD) Testing Market Size (M USD), 2019-2030
Figure 5. Global Minimal Residual Disease (MRD) Testing Market Size (M USD) (2019-2030)
Figure 6. Global Minimal Residual Disease (MRD) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Minimal Residual Disease (MRD) Testing Market Size by Country (M USD)
Figure 11. Minimal Residual Disease (MRD) Testing Sales Share by Manufacturers in 2023
Figure 12. Global Minimal Residual Disease (MRD) Testing Revenue Share by Manufacturers in 2023
Figure 13. Minimal Residual Disease (MRD) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Minimal Residual Disease (MRD) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Minimal Residual Disease (MRD) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Minimal Residual Disease (MRD) Testing Market Share by Type
Figure 18. Sales Market Share of Minimal Residual Disease (MRD) Testing by Type (2019-2024)
Figure 19. Sales Market Share of Minimal Residual Disease (MRD) Testing by Type in 2023
Figure 20. Market Size Share of Minimal Residual Disease (MRD) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Minimal Residual Disease (MRD) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Minimal Residual Disease (MRD) Testing Market Share by Application
Figure 24. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Application in 2023
Figure 26. Global Minimal Residual Disease (MRD) Testing Market Share by Application (2019-2024)
Figure 27. Global Minimal Residual Disease (MRD) Testing Market Share by Application in 2023
Figure 28. Global Minimal Residual Disease (MRD) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Minimal Residual Disease (MRD) Testing Sales Market Share by Country in 2023
Figure 32. U.S. Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Minimal Residual Disease (MRD) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Minimal Residual Disease (MRD) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Minimal Residual Disease (MRD) Testing Sales Market Share by Country in 2023
Figure 37. Germany Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Minimal Residual Disease (MRD) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Minimal Residual Disease (MRD) Testing Sales Market Share by Region in 2023
Figure 44. China Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Minimal Residual Disease (MRD) Testing Sales and Growth Rate (K Units)
Figure 50. South America Minimal Residual Disease (MRD) Testing Sales Market Share by Country in 2023
Figure 51. Brazil Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Minimal Residual Disease (MRD) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Minimal Residual Disease (MRD) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Minimal Residual Disease (MRD) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Minimal Residual Disease (MRD) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Minimal Residual Disease (MRD) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Minimal Residual Disease (MRD) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Minimal Residual Disease (MRD) Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Minimal Residual Disease (MRD) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Minimal Residual Disease (MRD) Testing Market Size (M USD), 2019-2030
Figure 5. Global Minimal Residual Disease (MRD) Testing Market Size (M USD) (2019-2030)
Figure 6. Global Minimal Residual Disease (MRD) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Minimal Residual Disease (MRD) Testing Market Size by Country (M USD)
Figure 11. Minimal Residual Disease (MRD) Testing Sales Share by Manufacturers in 2023
Figure 12. Global Minimal Residual Disease (MRD) Testing Revenue Share by Manufacturers in 2023
Figure 13. Minimal Residual Disease (MRD) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Minimal Residual Disease (MRD) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Minimal Residual Disease (MRD) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Minimal Residual Disease (MRD) Testing Market Share by Type
Figure 18. Sales Market Share of Minimal Residual Disease (MRD) Testing by Type (2019-2024)
Figure 19. Sales Market Share of Minimal Residual Disease (MRD) Testing by Type in 2023
Figure 20. Market Size Share of Minimal Residual Disease (MRD) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Minimal Residual Disease (MRD) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Minimal Residual Disease (MRD) Testing Market Share by Application
Figure 24. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Application in 2023
Figure 26. Global Minimal Residual Disease (MRD) Testing Market Share by Application (2019-2024)
Figure 27. Global Minimal Residual Disease (MRD) Testing Market Share by Application in 2023
Figure 28. Global Minimal Residual Disease (MRD) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Minimal Residual Disease (MRD) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Minimal Residual Disease (MRD) Testing Sales Market Share by Country in 2023
Figure 32. U.S. Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Minimal Residual Disease (MRD) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Minimal Residual Disease (MRD) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Minimal Residual Disease (MRD) Testing Sales Market Share by Country in 2023
Figure 37. Germany Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Minimal Residual Disease (MRD) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Minimal Residual Disease (MRD) Testing Sales Market Share by Region in 2023
Figure 44. China Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Minimal Residual Disease (MRD) Testing Sales and Growth Rate (K Units)
Figure 50. South America Minimal Residual Disease (MRD) Testing Sales Market Share by Country in 2023
Figure 51. Brazil Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Minimal Residual Disease (MRD) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Minimal Residual Disease (MRD) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Minimal Residual Disease (MRD) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Minimal Residual Disease (MRD) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Minimal Residual Disease (MRD) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Minimal Residual Disease (MRD) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Minimal Residual Disease (MRD) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Minimal Residual Disease (MRD) Testing Market Share Forecast by Application (2025-2030)
